Could be worse: Nulasta is a long-acting form of GCSG (filgrastim) that reduces the duration and depth of low white blood cell count (WBC), particularly the neutrophil count (ANC) after chemotherapy. It won't completely prevent a WBC drop, so the dosage or timing of subsequent rounds of chemotherapy may need to be adjusted, in individual cases.
Answered 9/2/2017
563 views
2 doctors weighed in across 2 answers
A doctor has provided 1 answer
3 doctors weighed in across 3 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question